Gene therapy, hemostatic rebalancing therapies, memetic therapies, and even factor replacement therapy are all currently being explored in clinical trials, but while these therapies are paving the way to historical treatment ease and efficacy, they are also sweeping the hemophilia community into uncharted territory of potentially new challenges that must be addressed. This episode explores the current state of novel therapy investigation in hemophilia.
Contributors:
Dr. Maria Elisa Mancuso
Dr. Glenn Pierce
Dr. Steven Pipe
Dr. Lindsey George
Dr. Margareth Ozelo
Dr. Guy Young
Dr. Michael Recht
Dr. Rich Gorman
Mark Skinner
Luke Pembroke
Senior Advisor:
Dr. Donna DiMichele
Links to learn more:
Show Notes:
Featured Advertiser: Sanofi
Subscribe to BloodStream Media's Global Hemophilia Report
Connect with the Global Hemophilia Report
Global Hemophilia Report on LinkedIn
Global Hemophilia Report on Twitter
Global Hemophilia Report on Facebook
Connect with BloodStream Media:
